During the past decade, Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III" are "New-onset Type 1 Diabetes" (1 trials) and "New-onset type1 Diabetes" (1 trials). Many other conditions were trialed in "Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III" in a lesser frequency.

Most popular intervention types in "Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ladarixin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".